ArticleMedicine2018

A case report of remission of refractory membranous nephropathy progressing to stage 4 chronic kidney disease using low-dose rituximab: A long-term follow-up.

Xu-Jie Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.